Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Transcriptomic profiling to identify subsets of immune hot locally advanced rectal adenocarcinomas with favorable outcomes after neoadjuvant treatment.
Authors
Francisco Sanchez Vega
Memorial Sloan Kettering Cancer Center, New York, NY
Francisco Sanchez Vega , Walid Khaled Chatila , Jin Ki Kim , Henry S. Walch , Michael Marco , Ching-Tung Chen , Fan Wu , Danny Khalil , Karuna Ganesh , Xuan Qu , Anisha Luthra , Seo-Hyun Choi , Yu-jui Ho , Dana Omer , Jinru Shia , Paul Bernard Romesser , Nikolaus Schultz , Rona Yaeger , Jesse Joshua Smith , Julio Garcia-Aguilar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Translational Research
DOI
10.1200/JCO.2022.40.4_suppl.155
Abstract #
155
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Comprehensive transcriptomic analysis of immune checkpoint markers in a pancancer cohort: Implications for response and resistance.
First Author: Hirotaka Miyashita
Poster
2023 ASCO Annual Meeting
Pan-cancer analysis of IDO1 transcriptome expression and its impact on outcome in patients treated with immune checkpoint inhibitors.
First Author: Yu Fujiwara
Poster
2020 Gastrointestinal Cancers Symposium
ARID1A mutation to define an immunologically active subgroup in patients with microsatellite-stable colorectal cancer.
First Author: Amir Mehrvarz Sarshekeh
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.
First Author: Karam Ashouri